GlaxoSmithKline (GSKL)

1,309.50p
   
  • Change Today:
      0.075p
  • 52 Week High: 1,812.75p
  • 52 Week Low: 1,302.00p
  • Currency: UK Pounds
  • Shares Issued: 4,870.09m
  • Volume: 1,034,469
  • Market Cap: £63,774m

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 30,328.00 29,324.00 24,696.00 34,099.00 33,754.00
Operating Profit/(Loss) 6,745.00 6,433.00 4,357.00 7,783.00 6,961.00
Profit Before Tax 6,064.00 5,628.00 3,599.00 6,968.00 6,221.00
Profit After Tax 5,308.00 4,921.00 3,516.00 6,388.00 5,268.00
           
Earnings per Share - Basic 121.60p 110.80p 66.32p 115.50p 93.90p
Earnings per Share - Adjusted 155.10p 139.70p 90.56p 115.90p 123.90p
           
Dividend per Share 42.00p 44.00p 80.00p 80.00p 80.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 9,957.00 9,620.00 10,672.00 11,006.00 10,348.00
Intangible Assets 21,579.00 21,364.00 40,631.00 40,421.00 41,517.00
Other Non-Current Assets 7,633.00 6,852.00 6,894.00 5,333.00 6,082.00
  40,361.00 39,377.00 60,429.00 60,184.00 60,201.00
Current Assets          
Inventories 5,498.00 5,146.00 5,783.00 5,996.00 5,947.00
Cash at Bank & in Hand 2,936.00 3,723.00 4,274.00 6,292.00 4,707.00
Other Current Assets 579.00 693.00 696.00 1,007.00 1,373.00
  18,644.00 20,769.00 18,674.00 20,247.00 19,491.00
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 59,005.00 60,146.00 79,103.00 80,431.00 79,692.00
Current Liabilities          
Borrowings 2,813.00 3,952.00 3,601.00 3,725.00 6,918.00
Other Current Liabilities 18,255.00 18,858.00 20,069.00 18,423.00 17,132.00
           
Current Liabilities 21,068.00 22,810.00 23,670.00 22,148.00 24,050.00
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Borrowings 15,205.00 17,035.00 20,572.00 23,425.00 23,590.00
Other Non-Current Liabilities 9,131.00 9,384.00 9,333.00 9,743.00 9,215.00
Non-Current Liabilities 25,142.00 27,240.00 34,091.00 37,475.00 37,285.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 46,210.00 50,050.00 57,761.00 59,623.00 61,335.00
           
Net Assets 12,795.00 10,096.00 21,342.00 20,808.00 18,357.00
           
Shareholders Funds 13,347.00 10,598.00 15,055.00 14,587.00 11,984.00
           
Minority Interests/Other Equity (552.00) (502.00) 6,287.00 6,221.00 6,373.00
Total Equity 12,795.00 10,096.00 21,342.00 20,808.00 18,357.00
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities 6,768.00 7,403.00 7,952.00 8,441.00 8,020.00
Net Cash Flow from Investing Activities (1,595.00) (8,772.00) (1,777.00) 2,161.00 (5,354.00)
Net Cash Flow from Financing Activities (5,641.00) 823.00 (7,589.00) (10,132.00) (1,840.00)
Net Increase/Decrease In Cash (468.00) (546.00) (1,414.00) 470.00 826.00
Ratios - based on IFRS 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
PE Ratio - Adjusted 9.4 10.3 22.2 14.5 17.9
PEG - Adjusted 0.9 0.2 n/a n/a 4.5
Earnings per Share Growth - Adjusted 11% 54% -22% -6% 4%
Dividend Cover 3.69 3.17 1.13 1.45 1.55
Revenue per Share 748.47p 728.37p 6.23p 685.27p 682.31p
Pre-Tax Profit per Share 149.65p 139.79p 0.91p 140.03p 125.75p
Operating Margin 22.24% 21.94% 17.64% 22.82% 20.62%
Return on Capital Employed 67.14% 61.02% 0.48% 65.99% 59.48%
           
Dividend Yield 2.9% 3.1% 4.0% 4.8% 3.6%
Dividend per Share Growth (4.55%) (45.00%) n/a n/a n/a
Operating Cash Flow per Share 167.03p 183.88p 198.65p 169.63p 162.12p
Cash Incr/Decr per Share (11.55p) (13.56p) (0.36p) 9.45p 16.70p
Net Asset Value per Share (exc. Intangibles) (216.78p) (279.88p) (481.86p) (394.15p) (468.16p)
Net Gearing 113.00% 162.90% 132.18% 142.99% 215.30%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page